Zurcher Kantonalbank (Zurich Cantonalbank) Foghorn Therapeutics Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$30.1 Billion
Q2 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2023 Jan 30, 2024	SELL	$2.94 - $6.76 $7,379 - $16,967	-2,510 Reduced 99.92%	2 $0
Q3 2023 Oct 25, 2023	BUY	$5.0 - $9.87 $12,560 - $24,793	2,512 New	2,512 $12,000

Others Institutions Holding FHTX

# of Institutions

Shares Held

32.7M

Call Options Held

Put Options Held

1.8K

Flagship Pioneering Inc. Cambridge, MA

12.7M
Shares

$102 Million
8.71% of portfolio
Bvf Inc San Francisco, CA

5.3M
Shares

$42.8 Million
0.93% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

2.52M
Shares

$20.3 Million
0.3% of portfolio
Raymond James & Associates St Petersburg, FL

2.3M
Shares

$18.5 Million
0.01% of portfolio
Euclidean Capital LLC New York, NY

1.57M
Shares

$12.7 Million
1.14% of portfolio

View Full List

About Foghorn Therapeutics Inc.

Ticker FHTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,637,400
Market Cap $336M
Description
Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...

More about FHTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account